Results 111 to 120 of about 13,526 (188)

Nintedanib Treatment of Patients With Interstitial Lung Diseases: A Retrospective Study of Daily Clinical Practice. [PDF]

In Vivo
Miyazaki K, Sato S, Kodama T, Kawakami T, Yazaki K, Matsuyama M, Tamura T, Numata T, Hayashi S, Inui T, Maezawa Y, Satoh H, Shiozawa T, Kikuchi N, Hizawa N.   +14 more
europepmc   +1 more source

Nintedanib-Associated Generalized Body Swelling in a Patient With Idiopathic Pulmonary Fibrosis: A Case Report. [PDF]

Cureus
Alghulayqah AI.
europepmc   +1 more source

Nintedanib in the prevention of radiation-induced lung injury in patients with unresectable stage II-III NSCLC: A protocol for a randomized, multicenter, control group study. [PDF]

PLoS One
Cui A, Shi A, Deng L, Sun Y, Yu J, Lian X, Zhao Z.   +6 more
europepmc   +1 more source

Nintedanib increases BCL-2 in fibrotic fibroblasts, enhancing ABT-199 apoptosis and fibrosis resolution. [PDF]

Am J Respir Cell Mol Biol
Cooley JC, Penick SK, Wilson JA, Javkhlan N, Foster DG, Edelman BL, Schott CA, Humphries SM, Lynch DA, Schwartz DA, Riches DWH, Redente EF.   +11 more
europepmc   +1 more source

Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-year Real-life Study. [PDF]

Thorac Res Pract
Mammadova A.
europepmc   +1 more source

Association of <i>PDGFRB</i>, <i>VEGFR2</i>, and <i>TGFB1</i> Gene Polymorphisms with Nintedanib Efficacy and Adverse Effects in Patients with Progressive Pulmonary Fibrosis. [PDF]

Int J Mol Sci
Djurdjevic N, Pjevic MD, Stjepanovic M, Colic N, Dimic-Janjic S, Jankovic J, Maric N, Zecevic A, Terzic M, Golubovic A, Milivojevic I, Omcikus M, Ilic B, Lukic K, Mijatovic S, Grk M.   +15 more
europepmc   +1 more source

Synergistic toxicity and clinical prioritization of docetaxel combined with nintedanib for non-small cell lung cancer: a real-world safety analysis using the FAERS database. [PDF]

Front Oncol
Zhang Q, Feng Q, Lei S, Yang W, Zhang W, Liu X.   +5 more
europepmc   +1 more source

Hypothesis-driven salvage therapy with corticosteroids, tofacitinib, and nintedanib for progressive radiation pneumonitis with possible immune-mediated contribution: a case report. [PDF]

Front Immunol
Yu X, Xu B, Sun J, Wang H, Guo Y, Ren D.
europepmc   +1 more source

Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosis. [PDF]

Am J Respir Crit Care Med
Kim JS, Loe A, Ma SF, Ranjan P, Lipinski JH, Mikhail SG, Gurczynski SJ, Zhou X, Huffnagle GB, Downward JE, Metcalf JD, Falkowski N, Stringer KA, Dickson RP, Huang Y, Moore BB, Martinez FJ, Murray S, Noth I, O'Dwyer DN.   +19 more
europepmc   +1 more source

MICA-129Met/Val as a therapeutic compass in idiopathic pulmonary fibrosis: prognosis and antifibrotic benefit. [PDF]

Front Immunol
Mocci S, Mereu C, Littera R, Deidda S, Cannas F, Lorrai M, Zedda E, Murgia M, Sanna C, Giuressi E, Lai S, Perra A, Floris M, Giglio S.   +13 more
europepmc   +1 more source